原发性第四脑室出口梗阻所致脑积水:单中心经验与文献回顾
该研究回顾性分析了2006至2019年收治的非交通性四脑室脑积水患者,其中8例为原发性第四脑室出口梗阻(PFVOO),占3.8%,并结合文献共62例分析。最常见表现为头痛、步态障碍或颅内高压症状。多数患者(54.8%)接受内镜下第三脑室造瘘术(ETV),ETV失败率28.6%,开颅手术失败率9%,内镜下Magendie造口术无失败记录。ETV治疗失败风险显著高于其他方式(P < 0.0005)。
要点
- PFVOO是罕见脑积水病因,ETV失败风险显著高于其他术式。
- 内镜下Magendie造口术在本组中无治疗失败记录。
- 开颅手术联合或不联合分流失败率较低,仍为推荐替代方案。
核心结论
- 尽管PFVOO属于梗阻性脑积水,但ETV治疗失败风险显著高于其他治疗方式(P < 0.0005)。
- 所提出的替代治疗方式(开颅手术、分流、内镜下Magendie造口术)仍被推荐。
研究设计与样本
- 回顾性分析2006至2019年收治的非交通性四脑室脑积水患者,筛选出PFVOO亚组。
- 共发现62例PFVOO患者,其中8例在本机构治疗,占非交通性脑积水患者的3.8%。
- 同时进行了PFVOO病例的文献综述。
主要发现
- 患者最常见表现为头痛、步态障碍或颅内高压症状。
- 本机构患者平均随访75.4个月,文献中平均随访29.9个月。
- 54.8%的患者接受ETV治疗,17.7%仅接受枕下开颅术,9.7%接受开颅联合分流手术,12.9%接受内镜下Magendie造口术。
- ETV治疗失败率为28.6%,开颅手术失败率为9%,内镜下Magendie造口术后无失败记录。
- ETV治疗失败风险显著高于其他治疗方式(P < 0.0005)。
临床怎么用
- 对于PFVOO所致脑积水,选择ETV需警惕较高的失败风险。
- 可考虑内镜下Magendie造口术、开颅手术或分流手术作为替代治疗方式。
局限性
- 本研究为单中心回顾性分析,样本量小(本机构仅8例)。
- 需要更大规模的多中心研究来确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Primary fourth ventricle outlet obstruction (PFVOO) is a rare cause of hydrocephalus with an unclear etiopathogenesis, and thus, consensus regarding the recommended treatment protocol is lacking. This study aims to summarize current knowledge of this condition in the light of our own treatment experience. METHODS: Retrospective analysis was carried out of all patients treated for noncommunicating tetraventricular hydrocephalus between 2006 and 2019, from which a subgroup of patients with PFVOO was created. A literature review of PFVOO cases was also carried out. RESULTS: A total of 62 patients with PFVOO were discovered, of whom 8 were treated at our institution, representing 3.8% of our patients with noncommunicating hydrocephalus. Patients most commonly presented with headaches, gait disturbance, or symptoms of intracranial hypertension. The mean follow-up duration was 75.4 months among our patients and 29.9 months in the literature. Most patients (54.8%) were treated by endoscopic third ventriculostomy (ETV), with the remainder undergoing suboccipital craniotomy alone (17.7%) or in combination with shunt surgery (9.7%), or endoscopic magendieplasty (12.9%). Treatment failure was noted in 28.6% of ETVs and 9% of craniotomies. No failures were recorded after endoscopic magendieplasty. The risk of treatment failure was found to be significantly higher with ETV compared with other treatment modalities (P < 0.0005). CONCLUSIONS: Despite the fact that PFVOO can be defined as an obstructive hydrocephalus, there seems to be a higher risk of ETV failure in such cases. The alternative treatment modalities presented are still recommended. Confirmation of these findings requires a larger multicenter study.
引用
- Krejčí O, Krejčí T, Mrůzek M, et al. Hydrocephalus Caused by Primary Fourth Ventricle Outlet Obstruction: Our Experience and Literature Review. World Neurosurg. 2021. PMID: 33444837. doi:10.1016/j.wneu.2021.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。